Categories: Uncategorized

Drugs contraindicated in Cats

DRUGS CONTRAINDICATED IN CATS

NSAIDs

ACETAMINOPHEN (PARACETAMOL)

Mechanism of Action-Prostaglandin’s synthesis is weakly inhibited like selective cyclooxygenase-2 inhibitors and also decreased concentration of prostaglandins.

Reason of toxicity -Deficient in glucuronidation and sulfation abilities, N-acetyl- p- benzoquinoneimin e (NAPQI) formed alternatively bind and damage the hepatic cell membrane leading to its injury and death subsequently 


ASPIRIN

Mechanism of Action-Cyclooxygenase e nzyme inactivation irreversibly leads to suppression of the thromboxanes & prostaglandins.

Reason of toxicity - Less of glucuronyl transferase and glycine conjugation


SALICYLATES
 

Mechanism of Action- Nonselective inhibition of peripherally and centrally mediated cyclooxygenase. Potent inhibitor of thromboxane production function.

Reason of toxicity- Relatively deficient in glucuronosyl transferase, which conjugates salicylate with glucuronic acid.

IBUPROFEN, CARPROFEN, ETODOLAC

Mechanism of Action- Inhibition of cyclooxygenase activity, blocking the production of prostaglandins, substances that the body releases in response to illness and injury.

Reason of toxicity-Low capacity for hepatic glucuronidation, needed for elimination.

MELOXICAM, PIROXICAM

Mechanism of Action-Preferential inhibition of COX-2 and sparing COX-1 alone.

Reason of toxicity-Low capacity for hepatic glucuronidation, needed for elimination.

Antibiotics

APRAMYCIN

Mechanism of Action-Inhibition of microbial protein synthesis accomplished through binding to the bacterial 30S small ribosomal subunits

Reason of toxicity -These drugs are concentrated in the labyrinthine fluid and vestibular/cochlea r sensory cells and hairs undergo concentration dependent destructive changes.


CHLORAMPHENICOL

Mechanism of Action-Inhibition of microbial protein synthesis accomplished through reversibly binding to the 50S subunit of the bacterial ribosome and inhibition of the peptidyl transferase step of protein synthesis.

Reason of toxicity -Needs to be metabolized in liver as Chloramphenicol glucuronide

Anti parasites

AMITRAZ

Mechanism of Action-Activates alpha-2 adrenergic receptor in the central nervous system (CNS), alpha2 and alpha1 adrenergic receptor in the peripheral nervous system (PNS).

Reason of toxicity -Stimulation of α2- adrenergic receptors that generates the main signs of amitraz poisoning, such as loss of consciousness, breathing depression, seizures, bradycardia, hypotension, and hypothermia


PYRETHRINS & PYRETHROID

Mechanism of Action-Axonic excitotoxins, the toxic effects of which are mediated through preventing the closure of the voltage-gated sodium channels in the axonal membranes in muscle and nervous tissue

Reason of toxicity -Lack of the metabolising enzyme glucuronosyl transferase


SALINOMYCIN

Mechanism of Action-Inhibition of ookinete development, oocyst formation in the mosquito midgut, blocking their transmission Selectively damages infected erythrocytes.

Reason of toxicity-Polyneuropathy of the peripheral nerves, characterized by primary axonal degeneration and secondary degeneration of the myelin sheath resulting in paralysis. hypoxia of the myocardium due to dyspnoea from paralysis of the respiratory musculature

Anaesthetics

BENZOCAINE

Mechanism of Action-Stabilizes the neuronal membrane reversibly, decreasing its permeability to sodium ions, inhibition of depolarization of the neuronal membrane blocking of initiation and conduction of nerve impulses.

Reason of toxicity -Due to their unique hemoglobin structure, it is easily damaged


PROPOFOL

Mechanism of Action-Decreases the rate of dissociation of the Gamma- aminobutyric acid (GABA) from the receptor, duration of the GABA- activated opening of the chloride channel increased resulting hyperpolarization of cell membranes.

Reason of toxicity -Lack of glucuronosyl transferase which is needed to glucuronidate propofol.

References

  1. Shrestha B, Reed JM, Starks PT, Kaufman GE, Goldstone JV, Roelke ME et al. Evolution of a major drug metabolizing enzyme defect in the domestic cat and other felidae: phylogenetic timing and the role of hypercarnivory. PloS one 2011;6(3):e18046.
  2. Court MH. Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms. The Veterinary Clinics of North America. Small Animal Practice 2013;43(5).
  3. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man. The FASEB journal 2008;22(2):383-90.
  4. Rao GH, Johnson GG, Reddy KR, White JG. Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis: An Official Journal of the American Heart Association, Inc 1983;3(4):383-8.
  5. Lascelles BD, Court MH, Hardie EM, Robertson SA. Non-steroidal anti-inflammatory drugs in cats: a review. Veterinary anaesthesia and analgesia 2007;34(4):228-50.
  6. Oishi N, Talaska AE, Schacht J. Ototoxicity in dogs and cats. Veterinary Clinics: Small Animal Practice 2012;42(6):1259-71.
  7. Watson AD, Middleton DJ. Chloramphenicol toxicosis in cats. American journal of veterinary research 1978;39(7):1199-203.
  8. Shukla P, Bansode FW, Singh RK. Chloramphenicol toxicity: A review. Journal of Medicine and Medical Sciences 2011;2(13):1313-6.
  9. Sutton NM, Bates N, Campbell A. Clinical effects and outcome of feline permethrin spot-on poisonings reported to the Veterinary Poisons Information Service (VPIS), London. Journal of Feline Medicine and Surgery
    2007;9(4):335-9.
  10. Boland LA, Angles JM. Feline permethrin toxicity:
    retrospective study of 42 cases. Journal of feline
    medicine and surgery 2010;12(2):61-71.
  11. Anadón A, Martínez-Larrañaga MR, Martínez MA. Use
    and abuse of pyrethrins and synthetic pyrethroids in veterinary medicine. The Veterinary Journal 2009;182(1):7-20.
  12. Andrade SF, Sakate M, Laposy CB, Valente SF, Bettanim VM, Rodrigues LT et al. Effects of experimental amitraz intoxication in cats. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 2007;59(5):1236-44
  13. Plumb DC. (Ed.) Veterinary Drug Handbook, 3 ed., Iowa State University Press, Ames 1999, 750.
  14. do Monte Barretto ML, de Deus Ferreira A, Pascoal IC, da Silva MB, de Torres SM, Falcão MV et al. Amitraz: pharmacological and toxicological aspects in animals. Medicina Veterinária (UFRPE) 2017;11(3):185-91.
  15. Van der Linde-Sipman JS, Van Den Ingh TS, Van Nes JJ, Verhagen H, Kersten JG, Beynen AC et al. Salinomycin- induced polyneuropathy in cats: morphologic and epidemiologic data. Veterinary pathology 1999;36(2):152-6.
  16. Patrascu J, Bedreag O, Papurica M, Biris M, Ancusa O, Onetiu D et al. Compatibility of ester-type anesthetic agents with two polysaccharides. Rev Chim 2014;65(8):921-4
  17. Takahashi H, Maruo Y, Mori A, Iwai M, Sato H, Takeuchi Y. Effect of D256N and Y483D on propofol glucuronidation by human uridine 5′‐diphosphate glucuronosyltransferase (UGT1A9). Basic & clinical pharmacology & toxicology 2008;103(2):131-6.
vetdrugs

Share
Published by
vetdrugs